QCDX LLC

Capabilities

The QCDx mission is to develop a transcendent, world-best liquid biopsy for precision diagnosis of cancer by detection and deep characterization of Circulating Tumor Cells (CTCs) for improving clinical outcomes and the patient’s quality of life. The company's Reveal Cell Heterogeneity™ technology aims to deliver on unmet needs for early cancer diagnosis, monitoring of treatment efficacy and surveillance for disease recurrence.